5-Bromo-N-(3-methoxyphenyl)furan-2-carboxamide

Catalog No.: 
ACFPRE363
CAS No.: 
75991-00-3
Molecular Formula: 
C12H10BrNO3
Molecular Weight: 
296.12
5-Bromo-N-(3-methoxyphenyl)furan-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$101.00InquiryInquiry
1g95%$221.00InquiryInquiry
5g95%$822.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-N-(3-methoxyphenyl)furan-2-carboxamide
IUPAC Name5-bromo-N-(3-methoxyphenyl)furan-2-carboxamide
MDL No.MFCD00438946
Molecular FormulaC12H10BrNO3
Molecular Weight296.12
SMILESO=C(C1=CC=C(Br)O1)NC2=CC=CC(OC)=C2
InChI KeyZBBUKBYFONNZIN-UHFFFAOYSA-N
SynonymCHEMBRDG-BB 5245867;5-bromo-N-(3-methoxyphenyl)-2-furamide(SALTDATA: FREE);5-BROMO-N-(3-METHOXYPHENYL)-2-FURAMIDE;5-bromofuran-2-carboxylic acid (3-methoxyphenyl)amide
CAS No.75991-00-3

Synthetic Route by SureRoute

1. ACFPRE363 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJXEI853 route compound structure diagram
    ACJXEI85327191-09-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFPRE363 route product structure diagram
    ACFPRE36375991-00-3
Inquiry

2. ACFPRE363 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJXEI853 route compound structure diagram
    ACJXEI85327191-09-9In Stock
  2. Plus
  3. ACLNUT108 route compound structure diagram
    ACLNUT10826726-16-9In Stock
  4. Then
  5. ACFPRE363 route product structure diagram
    ACFPRE36375991-00-3
Inquiry

3. ACFPRE363 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDYZJ937 route compound structure diagram
    ACDYZJ9372527-99-3In Stock
  2. Plus
  3. ACJXEI853 route compound structure diagram
    ACJXEI85327191-09-9In Stock
  4. Then
  5. ACFPRE363 route product structure diagram
    ACFPRE36375991-00-3
Inquiry

Comments (0)